- The 8 States Most Likely to Legalize Marijuana Next
- BlackBerry Is Finally Realizing Smartphones Aren't the Answer
- Express Scripts and AbbVie Drug-Pricing Deal Might Devastate Biotech Bull Market
- Dow 18,000: Why This Market Rally May Never Happen Again
- Gilead Sciences Is Not a Buy; It's Heading Lower on Price War: Jim Cramer
Israel's stock market has boomed the past two years, but the recent events in Egypt are giving some investors pause.
Barry Sheked believes keen competition can only help the software company.
Stocks are fueled by a host of bullish corporate and economic news.
Israel's largest cellular-phone carrier hopes to raise more than $300 million in an IPO.
Teva, Check Point and M-Systems are among the familiar names in the new country index.
A growing stake by BlackRock could suggest a shakeup at the top.
Shares of the Israeli generic-drug maker could take a hit.
Tzvika Friedman discusses his company's growth strategy in an increasingly competitive market.
Freescale's buyout gets hopes up for a 'wall of money' into the Israeli high-tech industry.